TARA HART: Open Payments
NPI 1134726284 · OWENSBORO, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$443 in 12 payments from 6 companies in 2025. Trend: 2023 $636 · 2024 $498 · 2025 $443
Food & beverage: $443
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 2 | $153 |
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| ABBVIE INC. | 6 | $105 |
| Gilead Sciences, Inc. | 1 | $25 |
| Alkermes, Inc. | 1 | $19 |
| Cipher Pharmaceuticals US LLC | 1 | $16 |
Products named: FANAPT, BREZTRI, UBRELVY, MAVYRET, HETLIOZ, VIVITROL, VRAYLAR, QULIPTA.
Industry payments across KY — which companies pay providers there.
